PolyPid Ltd (NAS:PYPD)
$ 3.55 0.15 (4.41%) Market Cap: 24.15 Mil Enterprise Value: 25.84 Mil PE Ratio: 0 PB Ratio: 10.63 GF Score: 37/100

Q2 2022 PolyPid Ltd Earnings Call Transcript

Aug 10, 2022 / 12:30PM GMT
Release Date Price: $182.25 (+2.79%)
Operator

Greetings, and welcome to the PolyPid Second Quarter 2022 Conference Call. (Operator Instructions) A reminder, this call is recorded.

And I would now like to introduce your host for today's conference, Bob Yedid from LifeSci Advisors. Mr. Yedid, you may begin.

Robert A. Yedid
LifeSci Advisors, LLC - MD

Thank you all for participating in PolyPid's second quarter 2022 earnings conference call. Joining me on the call today will be Dikla Czaczkes Akselbrad, Chief Executive Officer of PolyPid; and Ori Warshavsky, Chief Operating Officer for PolyPid's U.S. Operations.

Earlier today, PolyPid released financial results for the 3 and 6 months ended June 30, 2022. The A copy of the press release is available in the Investors section on the company's website.

I'd like to remind you that on this call, management will make forward-looking statements within the meaning of the federal securities laws. For example, management is making forward-looking statements when it discusses our ongoing clinical trials, our expectations regarding the timing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot